TORONTO, ON / ACCESSWIRE / August 11, 2021 / StageZero Life Sciences (“StageZero” or the “Company”) (TSX:SZLS) today announced that it will release its second quarter 2021 operational results before the market open on Tuesday, August 17, 2021. StageZero’s Chairman and CEO, James Howard-Tripp, will host a conference call and accompanying webcast at 8:30 a.m. EST on Tuesday, August 17, 2021, to review the operational results and discuss business developments.
Analyst and Investor Call
Event Date: Tuesday, August 17, 2021
Time: 8:30 a.m. EST
Webcast Link: https://www.webcaster4.com/Webcast/Page/2082/42373
Participant Numbers: Toll Free: +1 844-602-0380
International: +1-862-298-0970
Replay Number: Toll Free: +1-877-481-4010
International: +1-919-882-2331
Replay Passcode: 42373
About StageZero Life Sciences Ltd.
StageZero Life Sciences is dedicated to the early detection of multiple diseases through whole blood tests. The Company’s next-generation test, Aristotle®, is the first-ever multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood with high sensitivity and specificity for each cancer. StageZero’s full service, telehealth platform includes access to physicians and phlebotomists who can prescribe and draw samples for individuals and groups, and the Company operates a CAP accredited and CLIA certified high-complexity reference laboratory in Richmond, Virginia. In addition, leveraging its specialty in polymerase chain reaction (PCR) testing for the early identification of cancer through blood, StageZero also provides both COVID PCR testing (swab and saliva) and blood test analysis (Antibody testing). For more information, please visit www.stagezerolifesciences.com.
STAGEZERO LIFE SCIENCES LTD.
James Howard-Tripp
Chairman & CEO
For further information please contact:
Rebecca Greco
Investor Relations
Tel: 1-855-420-7140 ext. 1838
rgreco@stagezerols.com
SOURCE: StageZero Life Sciences Ltd
View source version on accesswire.com:
https://www.accesswire.com/659399/StageZero-to-Issue-Q2-2021-Financial-Results-and-Hold-Conference-Call-on-Tuesday-August-17
Burlington, Ontario--(Newsfile Corp. - January 7, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT"…
NEW YORK, Jan. 7, 2025 /PRNewswire/ -- Report with market evolution powered by AI -…
2025 Corporate Equality Index assesses LGBTQ+ workplace equality GALWAY, Ireland, Jan. 7, 2025 /PRNewswire/ --…
A Representation of the Best in Simulation Healthcare Education in 2024 ORLANDO, Fla., Jan. 7,…
Innovation & Entrepreneurship Leader to Accelerate ULP's Mission in Incubation, Acceleration, and Education IRVINE, Calif., Jan.…
TORRINGTON, Conn., Jan. 7, 2025 /PRNewswire/ -- Therap Services, the national leader in HIPAA-compliant electronic…